BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11908634)

  • 1. Effect of lactoferrin on Helicobacter felis induced gastritis.
    Dial EJ; Lichtenberger LM
    Biochem Cell Biol; 2002; 80(1):113-7. PubMed ID: 11908634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human lactoferrin is effective in the treatment of Helicobacter felis-infected mice.
    Dial EJ; Romero JJ; Headon DR; Lichtenberger LM
    J Pharm Pharmacol; 2000 Dec; 52(12):1541-6. PubMed ID: 11197084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic properties of bovine lactoferrin on Helicobacter pylori.
    Dial EJ; Hall LR; Serna H; Romero JJ; Fox JG; Lichtenberger LM
    Dig Dis Sci; 1998 Dec; 43(12):2750-6. PubMed ID: 9881510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human lactoferrin enhances the efficacy of triple therapy in mice infected with Helicobacter pylori.
    Yuan Y; Wu Q; Cheng G; Liu X; Liu S; Luo J; Zhang A; Bian L; Chen J; Lv J; Dong X; Yang G; Zhu Y; Ma L
    Int J Mol Med; 2015 Aug; 36(2):363-8. PubMed ID: 26080893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactoferrin and desferrioxamine are ineffective in the treatment of Helicobacter pylori infection and may enhance H. pylori growth and gastric inflammation in mice.
    Huynh HQ; Campbell MA; Couper RT; Tran CD; Lawrence A; Butler RN
    Lett Appl Microbiol; 2009 May; 48(5):517-22. PubMed ID: 19187488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic effect of bovine lactoferrin in the host infected with Helicobacter pylori.
    Wada T; Aiba Y; Shimizu K; Takagi A; Miwa T; Koga Y
    Scand J Gastroenterol; 1999 Mar; 34(3):238-43. PubMed ID: 10232866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics.
    de Bortoli N; Leonardi G; Ciancia E; Merlo A; Bellini M; Costa F; Mumolo MG; Ricchiuti A; Cristiani F; Santi S; Rossi M; Marchi S
    Am J Gastroenterol; 2007 May; 102(5):951-6. PubMed ID: 17313499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Helicobacter pylori infection by bovine milk glycoconjugates in a BAlb/cA mouse model.
    Wang X; Hirmo S; Willén R; Wadström T
    J Med Microbiol; 2001 May; 50(5):430-435. PubMed ID: 11339250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis: efficacy of bovine lactoferrin in Helicobacter pylori eradication.
    Sachdeva A; Nagpal J
    Aliment Pharmacol Ther; 2009 Apr; 29(7):720-30. PubMed ID: 19183156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human recombinant lactoferrin is ineffective in the treatment of human Helicobacter pylori infection.
    Guttner Y; Windsor HM; Viiala CH; Marshall BJ
    Aliment Pharmacol Ther; 2003 Jan; 17(1):125-9. PubMed ID: 12492741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
    Nakao K; Imoto I; Ikemura N; Shibata T; Takaji S; Taguchi Y; Misaki M; Yamauchi K; Yamazaki N
    Am J Gastroenterol; 1997 Jun; 92(6):1005-11. PubMed ID: 9177520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term zinc supplementation attenuates Helicobacter felis-induced gastritis in the mouse.
    Tran CD; Campbell MA; Kolev Y; Chamberlain S; Huynh HQ; Butler RN
    J Infect; 2005 Jun; 50(5):417-24. PubMed ID: 15907550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and long-term outcome of gastritis therapy in cheetahs (Acinonyx jubatus).
    Citino SB; Munson L
    J Zoo Wildl Med; 2005 Sep; 36(3):401-16. PubMed ID: 17312757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An atypical presentation of an acute gastric Helicobacter felis infection.
    Ghysen K; Smet A; Denorme P; Vanneste G; Haesebrouck F; Van Moerkercke W
    Acta Gastroenterol Belg; 2018; 81(3):436-438. PubMed ID: 30350536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid development of severe hyperplastic gastritis with gastric epithelial dedifferentiation in Helicobacter felis-infected IL-10(-/-) mice.
    Berg DJ; Lynch NA; Lynch RG; Lauricella DM
    Am J Pathol; 1998 May; 152(5):1377-86. PubMed ID: 9588906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study.
    Zullo A; De Francesco V; Scaccianoce G; Hassan C; Panarese A; Piglionica D; Panella C; Morini S; Ierardi E
    Dig Liver Dis; 2005 Jul; 37(7):496-500. PubMed ID: 15975536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lactoferrin supplementation on the effectiveness and tolerability of a 7-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection.
    Tursi A; Elisei W; Brandimarte G; Giorgetti GM; Modeo ME; Aiello F
    Med Sci Monit; 2007 Apr; 13(4):CR187-90. PubMed ID: 17392649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of lactoferrin for Helicobacter pylori eradication. Preliminary results.
    Di Mario F; Aragona G; Bò ND; Ingegnoli A; Cavestro GM; Moussa AM; Iori V; Leandro G; Pilotto A; Franzè A
    J Clin Gastroenterol; 2003; 36(5):396-8. PubMed ID: 12702979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of the ferret model of Helicobacter-induced gastritis to evaluation of antibacterial therapies.
    Alder JD; Ewing PJ; Mitten MJ; Oleksijew A; Tanaka SK
    Am J Gastroenterol; 1996 Nov; 91(11):2347-54. PubMed ID: 8931416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.